Literature DB >> 3293161

Do the beta-hemolytic non-group A streptococci cause pharyngitis?

N Cimolai1, R W Elford, L Bryan, C Anand, P Berger.   

Abstract

Implication of the beta-hemolytic non-group A streptococci (BHNAS) as pharyngeal pathogens has been based predominantly on reports of a few outbreaks, small case clusters, and anecdotes. These organisms have long been noted to constitute a significant number of the beta-hemolytic streptococcal isolates from throats of symptomatic and asymptomatic patients in a variety of populations. Laboratory studies have demonstrated the usefulness of anaerobic atmosphere and prolonged incubation in maximizing isolation of the BHNAS. More recently, genetic studies have furthered our appreciation of the taxonomy and have defined two major groups: Streptococcus anginosus-milleri group and large-colony BHNAS; the latter can be further separated on the basis of serogrouping and biotyping. Recognition of this diversity gives justification to the reexamination of the epidemiology and disease course of BHNAS pharyngitis. Treatment studies will also be required if all or subsets of these organisms can be confirmed as pharyngeal pathogens.

Entities:  

Mesh:

Year:  1988        PMID: 3293161     DOI: 10.1093/clinids/10.3.587

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  20 in total

1.  Penicillin for acute sore throat: randomised double blind trial of seven days versus three days treatment or placebo in adults.

Authors:  S Zwart; A P Sachs; G J Ruijs; J W Gubbels; A W Hoes; R A de Melker
Journal:  BMJ       Date:  2000-01-15

2.  Latex agglutination testing directly from throat swabs for rapid detection of beta-hemolytic streptococci from Lancefield serogroup C.

Authors:  G F Hayden; J C Turner; D Kiselica; M Dunn; J O Hendley
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

3.  Inverse association between Lancefield group G Streptococcus colonization and sore throat in slum and nonslum settings in Brazil.

Authors:  Sara Yee Tartof; Frances Farrimond; Juliana Arruda de Matos; Joice Neves Reis; Regina Terse Trindade Ramos; Aurelio Nei Andrade; Mitermayer Galvão dos Reis; Lee Woodland Riley
Journal:  J Clin Microbiol       Date:  2010-11-03       Impact factor: 5.948

4.  Beta-D-glucuronidase activity assay for rapid differentiation of species within beta-haemolytic group C and G streptococci.

Authors:  N Cimolai; D Mah
Journal:  J Clin Pathol       Date:  1991-10       Impact factor: 3.411

5.  Beta-haemolytic non-group A streptococci and pharyngitis: a case-control study.

Authors:  N Cimolai; B J Morrison; L MacCulloch; D F Smith; J Hlady
Journal:  Eur J Pediatr       Date:  1991-09       Impact factor: 3.183

6.  Liposome immunoassay for rapid identification of group A streptococci directly from throat swabs.

Authors:  M A Gerber; M F Randolph; K K DeMeo
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

7.  The epidemiology of beta-haemolytic non-group A streptococci isolated from the throats of children over a one-year period.

Authors:  N Cimolai; L MacCulloch; S Damm
Journal:  Epidemiol Infect       Date:  1990-02       Impact factor: 2.451

8.  Role of group C beta-hemolytic streptococci in pharyngitis: epidemiologic study of clinical features associated with isolation of group C streptococci.

Authors:  J C Turner; A Fox; K Fox; C Addy; C Z Garrison; B Herron; C Brunson; G Betcher
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

9.  Role of beta-hemolytic group C streptococci in pharyngitis: incidence and biochemical characteristics of Streptococcus equisimilis and Streptococcus anginosus in patients and healthy controls.

Authors:  K Fox; J Turner; A Fox
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

10.  M or M-like protein gene polymorphisms in human group G streptococci.

Authors:  N Schnitzler; A Podbielski; G Baumgarten; M Mignon; A Kaufhold
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.